Why the study?
Does the addition of isosorbide dinitrate to inotropic therapy improve haemodynamic parameters in patients with acute myocardial infarction and left ventricular failure?
Does the addition of isosorbide dinitrate to inotropic therapy improve haemodynamic parameters in patients with acute myocardial infarction and left ventricular failure?
In acute left ventricular failure complicating myocardial infarction, combining a venodilator with inotropic therapy provides additional haemodynamic benefits by further reducing elevated left heart filling pressure.
Answers are grounded in this paper and cite their sources.
May support adding isosorbide dinitrate to inotropes for further hemodynamic benefit in acute MI with LV failure; hypothesis-generating and should not change practice.
The effects of four inotropic agents with differing ancillary properties [a cardiac glycoside (digoxin), a combined alpha- and beta-adrenergic agonist (dobutamine), a beta-adrenergic agonist (prenalterol), and a phosphodiesterase inhibitor (amrinone)] alone and with subsequent addition of isosorbide dinitrate were compared in 48 consecutive acute myocardial infarction patients with radiographic and haemodynamic (pulmonary artery occluded pressure greater than 18 mm Hg) left ventricular failure. All agents with the exception of dobutamine reduced the elevated left heart filling pressure; only digoxin and dobutamine augmented the cardiac stroke volume index. All drugs except digoxin reduced the SVRI; an arteriolar constrictor response was evident 60 min after digoxin and a tachycardia resulted after combined alpha- and beta- and beta-adrenergic stimulations (dobutamine and prenalterol, respectively). The addition of isosorbide dinitrate reversed the inotrope-induced elevations of systemic arterial pressure and resulted in additional reductions in left heart filling pressure. These data suggest that, in the absence of substantial venodilator properties in an inotropic compound, reduction in elevated left heart filling pressure is not achieved with inotropic therapy alone in acute left ventricular failure and combining a venodilator may be haemodynamically advantageous.
No takes yet. Share an insight, caveat, or question.
Verma et al. (1992) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: